In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1730 News Items found
Breast cancer oncologist Neil Iyengar, MD, is seen talking with a patient.
Cancer Benefits and Risks From Ozempic, Wegovy, and Other Weight Loss Drugs

Learn what Ozempic, Wegovy, and other weight loss drugs mean for cancer risk and treatment, from an expert at MSK.
Feature
Amy Speck
Robotic Neurosurgery at MSK Speeds Recovery From Some Spinal Tumors

MSK surgeons have regularly used robotic surgery since 2007 to remove certain tumors in the chest and abdominal cavity. Now they are using robotic surgery to remove noncancerous tumors of the spine.
Caregiving
Patient standing next to MSK oncologist Dr. Leonard Wexler, both smiling
New Program to Get a Better Night’s Sleep in the Hospital

Read about an MSK pilot study that could help patients get better sleep in the hospital overnight.
An MSK scientists works in the lab
MSK Research Highlights, August 13, 2024

New MSK research found patients with non-small cell lung cancer brain metastases may benefit from up-front stereotactic radiosurgery; identified a connection between antibiotic use and autoimmune diseases; and uncovered a previously unknown structural role for messenger RNAs in the cytoplasm of cells.
MSK neuro-oncologist Ingo Mellinghoff
FDA Approves Drug for Low-Grade Glioma With IDH Gene Mutation

A new drug could be an effective treatment for some people with low-grade glioma.
MSK case manager Mercedes Tolentino-Nacion
The Unsung Heroes of Cancer Care: Getting Patients What They Need When They Go Home

Learn how case managers play an essential role in making sure patients are supported when they leave the hospital for home.
In the Clinic
Dr. Sandra D'Angelo
FDA Approves First Engineered Cell Therapy for Treating Rare Sarcoma

The FDA has approved an engineered cell therapy called afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for treating advanced synovial sarcoma. The clinical trials resulting in the drug’s approval were led by Dr. Sandra D’Angelo of MSK.
MSK lab coat
MSK Researchers Discover Source of Deadly Fungal Infections in Bone Marrow Transplant Patients, New Study Finds

A team of researchers led by Memorial Sloan Kettering Cancer Center (MSK) and collaborators at Emory University are shedding new light on deadly fungal infections that develop in bone marrow transplant patients.
Article
MSK hematologic oncologist Lia Palomba talking to patient.
FDA Approves CAR T Cell Treatment for Resistant Mantle Cell Lymphoma

Learn how MSK researchers led the way in the approval of a new mantle cell lymphoma CAR T cell treatment.
Detail shot of a scientist purifying proteins
MSK Research Highlights, July 31, 2024

New MSK research showed giving chemotherapy shortly after a stem cell or bone marrow transplant from a less than perfectly matched donor greatly reduces the chances that the patient will develop graft-versus-host disease (GVHD); and sheds new light on cell state changes in prostate cancer.